DE2610986A1 - Neue 1-deoxyribofuranuronsaeurederivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel - Google Patents

Neue 1-deoxyribofuranuronsaeurederivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel

Info

Publication number
DE2610986A1
DE2610986A1 DE19762610986 DE2610986A DE2610986A1 DE 2610986 A1 DE2610986 A1 DE 2610986A1 DE 19762610986 DE19762610986 DE 19762610986 DE 2610986 A DE2610986 A DE 2610986A DE 2610986 A1 DE2610986 A1 DE 2610986A1
Authority
DE
Germany
Prior art keywords
carbon atoms
group
radical
substituents
straight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19762610986
Other languages
German (de)
English (en)
Inventor
Kurt Dipl Chem Dr Klemm
Otto Prof Kraupp
Erhard Verstorben Langenscheid
Wolfgang Dr Med Schoetensack
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Byk Gulden Lomberg Chemische Fabrik GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chemische Fabrik GmbH filed Critical Byk Gulden Lomberg Chemische Fabrik GmbH
Publication of DE2610986A1 publication Critical patent/DE2610986A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE19762610986 1975-03-18 1976-03-16 Neue 1-deoxyribofuranuronsaeurederivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel Withdrawn DE2610986A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU72078A LU72078A1 (US06262066-20010717-C00424.png) 1975-03-18 1975-03-18

Publications (1)

Publication Number Publication Date
DE2610986A1 true DE2610986A1 (de) 1976-09-30

Family

ID=19727883

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762610986 Withdrawn DE2610986A1 (de) 1975-03-18 1976-03-16 Neue 1-deoxyribofuranuronsaeurederivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel

Country Status (11)

Country Link
JP (1) JPS51115496A (US06262066-20010717-C00424.png)
AT (1) AT349656B (US06262066-20010717-C00424.png)
BE (1) BE839695A (US06262066-20010717-C00424.png)
CH (1) CH618708A5 (US06262066-20010717-C00424.png)
DE (1) DE2610986A1 (US06262066-20010717-C00424.png)
DK (1) DK140314B (US06262066-20010717-C00424.png)
FR (1) FR2304350A1 (US06262066-20010717-C00424.png)
GB (1) GB1504474A (US06262066-20010717-C00424.png)
IE (1) IE43457B1 (US06262066-20010717-C00424.png)
LU (1) LU72078A1 (US06262066-20010717-C00424.png)
NL (1) NL7602711A (US06262066-20010717-C00424.png)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4738954A (en) * 1985-11-06 1988-04-19 Warner-Lambert Company Novel N6 -substituted-5'-oxidized adenosine analogs
US4868160A (en) * 1985-11-06 1989-09-19 Warner-Lambert Company Method of treating psychosis using N6 -substituted -5'-oxidized adenosine analogs

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT350735B (de) * 1976-08-06 1979-06-11 Hoffmann La Roche Verfahren zur herstellung von neuen ribo- furanosyl-imidazolderivaten
EP2608794A4 (en) * 2010-08-26 2014-01-22 Univ Northeastern METHODS AND COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF OBESITY

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4738954A (en) * 1985-11-06 1988-04-19 Warner-Lambert Company Novel N6 -substituted-5'-oxidized adenosine analogs
US4868160A (en) * 1985-11-06 1989-09-19 Warner-Lambert Company Method of treating psychosis using N6 -substituted -5'-oxidized adenosine analogs

Also Published As

Publication number Publication date
BE839695A (fr) 1976-09-17
LU72078A1 (US06262066-20010717-C00424.png) 1977-01-31
DK140314C (US06262066-20010717-C00424.png) 1979-12-24
IE43457B1 (en) 1981-03-11
ATA193776A (de) 1978-09-15
JPS51115496A (en) 1976-10-12
DK140314B (da) 1979-07-30
CH618708A5 (en) 1980-08-15
AT349656B (de) 1979-04-25
GB1504474A (en) 1978-03-22
FR2304350B1 (US06262066-20010717-C00424.png) 1979-03-16
DK116876A (US06262066-20010717-C00424.png) 1976-09-19
FR2304350A1 (fr) 1976-10-15
IE43457L (en) 1976-09-18
NL7602711A (nl) 1976-09-21

Similar Documents

Publication Publication Date Title
AT392964B (de) Verfahren zur herstellung neuer optisch aktiver oder racemischer prostaglandinderivate
EP0135762B1 (de) Steroide
DE2056327A1 (de) Aminopunn Derivate
EP0022192B1 (de) 1-Alkadien-2,4-yl-2-hydroxymethyl-3,4,5-trihydroxy-piperidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE2832127C2 (de) 1-(2-Chloräthyl)-1-nitroso-3-substituierte-3-glycosylharnstoffe, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
EP0314011A2 (de) Purinderivate
DE2610986A1 (de) Neue 1-deoxyribofuranuronsaeurederivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
EP0262404B1 (en) Glucosylmoranoline derivatives
DE2610985A1 (de) Arzneimittel enthaltend beta-d-1 (6-amino-9h-purin-9-yl)-1-deoxyribofuranuronsaeurederivate
DE3721223C2 (US06262066-20010717-C00424.png)
EP0064635B1 (de) Aminocyclitderivate, ihre Herstellung und sie enthaltende Arzneimittel
EP0313935B1 (de) Enolether von 6-Chlor-4-hydroxy-2-methyl-N-(2-pyridyl)-2H-thieno(2,3-e)-1,2-thiazin-3-carbonsäureamid-1,1-dioxid, ein Verfahren zu ihrer Herstellung sowie ihre Verwendung
DE3881657T2 (de) 21-alkoxy-steroid-derivate.
EP0003286B1 (de) Ergopeptidalkaloid-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE69515922T2 (de) Analogen von Acronycine, Verfahren zu ihrer Herstellung und sie enthaltende pharmaceutische Zusammensetzungen
DE69609870T2 (de) 17beta-(2-oxo-tetrahydrofuran-4-yl)-thio-androstane derivate (17beta-(gamma-buttersäure-lacton)-thio derivate) zur behandlung von entzündungen, pharmazeutische präparate davon und ein verfahren zu ihrer herstellung
DE2460553A1 (de) 2-substituierte adenosin-5'-carboxylate
CH638817A5 (de) Nicht-glykosidische theophyllin-zucker-derivate und verfahren zu ihrer herstellung.
DE2535048A1 (de) Nitrosoharnstoffderivate und verfahren zur herstellung derselben
DE3703633A1 (de) Purin-derivate, ihre herstellung und sie enthaltende arzneimittel
DE2511829C2 (US06262066-20010717-C00424.png)
EP0196330B1 (de) Verwendung von pyrrothinderivaten
DE2632951A1 (de) Neue 1-deoxy-2,3-0-alkyliden-ribofuranuronsaeurederivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE3127972A1 (de) "11(alpha)-amino-androstane"
DE69104013T2 (de) Hexitolderivate.

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8139 Disposal/non-payment of the annual fee